You're signed outSign in or to get full access.
Foresite Capital Management VI LLC
Foresite Capital Management VI LLC is an entity associated with Foresite Capital, a multi-stage investment firm specializing in healthcare and life sciences markets. Headquartered in San Francisco, CA, the firm leverages data science and domain expertise to invest in biotech and healthcare technology companies. The broader Foresite Capital organization was founded in 2011 and manages multiple funds, serving institutional investors, family offices, and accredited individuals. The employee count at Foresite Capital is estimated at around 50.
Investment Strategy
Foresite Capital Management VI LLC focuses on multi-stage investments across healthcare and life sciences sectors, including biotechnology and healthcare technology startups. The firm employs a data science-driven approach, integrating deep industry expertise and network relationships to identify, evaluate, and support both early and late stage companies. Its investment philosophy emphasizes transforming healthcare through innovation, supporting companies with high scientific and commercial potential, and actively helping portfolio companies scale and achieve meaningful milestones.
Latest 13F Filing Activity
Foresite Capital Management VI LLC filed their most recent 13F report on Jun 30, 2025 disclosing 20 equity positions with a total 13F market value of $178M. The fund increased holdings in Rapt Therapeutics Inc., Hinge Health Inc., Verastem Inc. among other positions. Foresite Capital Management VI LLC reduced exposure to Rapt Therapeutics Inc., Alumis Inc., Edgewise Therapeutics Inc. among others.
Top Holdings
Equity Positions (20)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
C CGON | CG Oncology, Inc. | 32.47% | $57.8M | 2,221,474 | $28.68 | $26.00 | +$3.4M |
C CNTA | Centessa Pharmaceuticals Inc | 9.26% | $16.5M | 1,253,379 | $16.75 | $13.14 | -$1.6M |
A AKRO | Akero Therapeutics Inc | 7.35% | $13.1M | 244,900 | $27.82 | $53.36 | -$1.7M |
A ALMS | Alumis Inc | 7.16% | $12.7M | 4,247,670 | $7.81 | $3.00 | -$13.1M |
R RAPT | Rapt Therapeutics Inc | 7.03% | $12.5M | 1,562,500 | $8.00 | $8.00 | +$12.5M |
Industry Allocation
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more